he clinical content of preconception care : he use of medications and supplements mong women of reproductive age

[1]  S. Kane,et al.  American gastroenterological association institute medical position statement on the use of gastrointestinal medications in pregnancy. , 2006, Gastroenterology.

[2]  E. Schwarz,et al.  Prescription of teratogenic medications in United States ambulatory practices. , 2005, The American journal of medicine.

[3]  K. Rothman,et al.  Risk of specific congenital abnormalities in offspring of women with diabetes , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[4]  D. Reed-Gillette,et al.  Prevalence of leading types of dietary supplements used in the Third National Health and Nutrition Examination Survey, 1988--94. , 2004, Advance data.

[5]  P. Barnes,et al.  Complementary and alternative medicine use among adults: United States, 2002. , 2004, Advance data.

[6]  L. Mofenson.  Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States , 2003 .

[7]  J. Kendrick.  Preconception Care of Women With Diabetes , 1998, Diabetes Care.

[8]  W. Rayburn,et al.  Prenatal Use of Medications by Women Giving Birth at a University Hospital , 1997, Southern medical journal.

[9]  A. Czeizel.  Prevention of Neural Tube Defects , 1996 .

[10]  R. Brent,et al.  Environmental causes of human congenital malformations , 2008 .

[11]  Paxil and the risk of birth defects. , 2006, FDA consumer.

[12]  K. Uhl.  Conducting Clinical Pharmacology Studies in Pregnant and Lactating Women , 2004 .